Patent details

Basic Information

Publication number:

EP2249826

PCT Application Number:

PCT/US/2008/008647

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087945077

PCT Publication Number:

WO/2009/113989

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS AND METHODS OF USE OF COMPOUNDS TO INCREASE CANCER PATIENT SURVIVAL TIME

French Title of Invention:

COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE COMPOSÉS POUR AUGMENTER LE TEMPS DE SURVIE DE PATIENTS ATTEINTS DU CANCER

German Title of Invention:

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON VERBINDUNGEN ZUR VERLÄNGERUNG DER ÜBERLEBENSZEIT VON KREBSPATIENTEN

SPC Number:

Dates

Filing date:

15/07/2008

Grant date:

07/09/2016

EP Publication Date:

07/09/2016

PCT Publication Date:

17/09/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/11/2010

EP B1 Publication Date:

07/09/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/07/2017

Expiration date:

15/07/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/07/2008

 

 

Name:

BIONUMERIK PHARMACEUTICALS INC.

Address:

8023 Vantage Drive Suite - Lobby 1, San Antonio, TX 78230, United States (US)

Inventor

Name:

HAUSHEER Frederick, H.

Address:

United States (US)

Priority

1

Priority Number:

8/003405

Priority Date:

14/03/2008

Priority Country:

United States (US)

2

Priority Number:

75980

Priority Date:

14/03/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/337;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages